Emergence of rifampicin resistance during rifampicin-containing treatment in elderly patients with persistent methicillin-resistant staphylococcus aureus bacteremia

Journal of the American Geriatrics Society

Volumn 58, Issue 5, 2010, Pages 1001-1003

  Lai, Chih Cheng ^a   Tan, Che Kim ^b   Lin, Sheng Hsiang ^c   Liao, Chun Hsing ^d   Huang, Yu Tsung ^e   Hsueh, Po Ren ^e  

^a CARDINAL TIEN HOSPITAL   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c Taipei County Hospital   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIUM ISOLATION; BLOOD CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; GERIATRIC PATIENT; HOSPITAL CARE; HOSPITAL INFECTION; HUMAN; LETTER; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; TREATMENT DURATION; BACTEREMIA; DRUG EFFECTS; ISOLATION AND PURIFICATION; MICROBIOLOGY; PENICILLIN RESISTANCE; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; FEMALE; HUMANS; MALE; METHICILLIN RESISTANCE; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 77952202341     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2010.02842.x     Document Type: Letter

References (9)

1. Deresinski S. Vancomycin in combination with other antibiotics for the treatment of serious methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2009 49:1072 1079.
2. Tuazon C, Lin MY, Sheagren JN. In vitro activity of rifampicin alone and in combination with nafcillin and vancomycin against pathogenic strains of Staphylococcus aureus. Antimicrob Agents Chemother 1978 13:759 761. (Pubitemid 8323546)
3. Bahl D, Miller DA, Leviton I et al. In vitro activities of ciprofloxacin and rifampicin alone and in combination against growing and nongrowing strains of methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 1997 41:1293 1297. (Pubitemid 27231429)
4. Cosgrove SE, Vigliani GA, Fowler VG Jr. et al. Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic. Clin Infect Dis 2009 48:713 721.
5. McCabe WR, Jackson GG. Gram-negative bacteremia. Arch Intern Med 1962 110:847 864.
6. Performance Standards for Antimicrobial Susceptibility Testing. Sixteenth Informational Supplement. M100-S19.
7. Ju O, Woolley M, Gordon D. Emergence and spread of rifampicin-resistant, methicillin-resistant Staphylococcus aureus during vancomycin-rifampicin combination therapy in an intensive care unit. Eur J Clin Microbiol Infect Dis 2006 25:61 62. (Pubitemid 43207335)
8. Steele MA, Burk RF, DesPrez RM. Toxic hepatitis with isoniazid and rifampin. Chest 1991 99:465 471.
9. Blumberg HM, Burman WJ, Chaisson RE et al. American Thoracic Society, Centers for Disease Control and Prevention and the Infectious Diseases Society. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of tuberculosis. Am J Respir Crit Care Med 2003 167:603 662.